108
Views
5
CrossRef citations to date
0
Altmetric
Articles

GC-MS Analysis and Attenuation of Bleomycin-Induced Lung Fibrosis by Fractionated Methanolic Extract of Cissampelos Owariensis in Wistar Rats

, , & ORCID Icon
Pages 155-171 | Received 02 Apr 2019, Published online: 19 Nov 2019
 

ABSTRACT

Crude methanolic leaf extract of Cissampelos owariensis was fractionated using vacuum liquid chromatography and analyzed by gas chromatography–mass spectrometry (GC-MS). Male Wistar rats were induced pulmonary fibrosis (PF) by a single intraperitoneal administration of 0.75 U 100 g−1 bleomycin (BLM), divided equally into four groups and given orally fresh water (control), 10 mg kg−1 quercetin, 200, or 400 mg kg−1 crude methanol leaf extract (crudemet) of C. owariensis daily for 28 d. Plasmatic enzymes, antioxidants, and lipid peroxidation (LPO) were determined spectrophotometrically, and the histology of lung section was done microscopically. GC-MS revealed the presence of hexadecanoic, phytol, 9,12-octadecadienoic acid (z,z)-methyl ester. Lung fibrosis increased the plasmatic total protein and alkaline phosphatase (ALP) activities. The BLM-administered rats showed decreased sodium dismutase (SOD), glutathione (GSH) activity, and alveolar hyperplasia. Oral administration of crudemet of C. owariensis ameliorated total protein, ALP activity, and LPO levels. The bioactive agents present in the C. owariensis extract may have the potential of reducing pathophysiology through increased antioxidants, thereby reducing BLM-induced lung hyperplasia.

Acknowledgments

The authors appreciate the efforts of the Laboratory Technologist of Crawford University, Ogun State and support from Anchor University, Lagos, Nigeria.

Ethical Information

All procedures performed involving the use of animals were in accordance with the ethical standards of Crawford University, Department of Biological Sciences, Igbesa, Ogun State, Nigeria.

Declaration of interest statement

The authors declare no potential conflict of interest about this study

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.